Patents by Inventor Xavier SIMONNET

Xavier SIMONNET has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260061016
    Abstract: The present invention relates to an aqueous extract obtained from a plant of the genus Aster for cosmetic or therapeutic applications, in particular in the prevention and/or treatment of acne.
    Type: Application
    Filed: March 15, 2023
    Publication date: March 5, 2026
    Inventors: Vincent MUTEL, Julien HERITIER, Bruno SCHNYDER, Xavier SIMONNET
  • Patent number: 10813962
    Abstract: An extract obtained from Saxifraga sp., Astrantia major, or a combination thereof and a method of treating or relieving an inflammatory-skin related condition in a subject is provided. The method comprises administering or applying a composition comprising an effective amount of an extract from Saxifraga sp., Astrantia major or a combination thereof, and a carrier, wherein the effective amount of the extract inhibits tumor necrosis factor alpha and Interleukine-1beta activity. The inflammation may be inflammation of the skin and the composition may be a skin preparation for external use.
    Type: Grant
    Filed: May 3, 2017
    Date of Patent: October 27, 2020
    Assignee: TauDerma SA
    Inventors: Vincent Mutel, Xavier Simonnet, Bruno Schnyder
  • Patent number: 10391134
    Abstract: The present invention is directed to compositions, uses and methods useful in the prevention or treatment of Candida infections, in particular Candida albicans infections and in particular recurrent Candida infections notably vaginal and oral or buccal candidiasis.
    Type: Grant
    Filed: April 23, 2015
    Date of Patent: August 27, 2019
    Assignee: PHARMALP SA
    Inventors: Philippe Meuwly, Christian Abbet, Bruno Schnyder, Jean-Martin Denis, Xavier Simonnet
  • Publication number: 20190160124
    Abstract: An extract obtained from Saxifraga sp., Astrantia major, or a combination thereof and a method of treating or relieving an inflammatory-skin related condition in a subject is provided. The method comprises administering or applying a composition comprising an effective amount of an extract from Saxifraga sp., Astrantia major or a combination thereof, and a carrier, wherein the effective amount of the extract inhibits tumor necrosis factor alpha and Interleukine-1beta activity. The inflammation may be inflammation of the skin and the composition may be a skin preparation for external use.
    Type: Application
    Filed: May 3, 2017
    Publication date: May 30, 2019
    Inventors: Vincent Mutel, Xavier Simonnet, Bruno Schnyder
  • Publication number: 20170035821
    Abstract: The present invention is directed to compositions, uses and methods useful in the prevention or treatment of Candida infections, in particular Candida albicans infections and in particular recurrent Candida infections notably vaginal and oral or buccal candidiasis.
    Type: Application
    Filed: April 23, 2015
    Publication date: February 9, 2017
    Inventors: Philippe MEUWLY, Christian ABBET, Bruno SCHNYDER, Jean-Martin DENIS, Xavier SIMONNET